Author

Elliot P. Tague

Boston UniversityORCID 0000-0002-7129-5913Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:protein design· 1 Assay:protein sequence· 1

Frequent Co-Authors

John T. NgoiD· 2 shared Ahmad S. KhaliliD· 1 shared Hui-Shan LiiD· 1 shared Jeffrey B. McMahaniD· 1 shared Mary J. DunlopiD· 1 shared Nathan TagueiD· 1 shared Nicole M. L. Wong· 1 shared Wilson W. WongiD· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

John T. NgoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyACS Chemical BiologyPeer-reviewedMay 4, 2023

Controlled protein activities with viral proteases, antiviral peptides, and antiviral drugs

Elliot P. Tague, Jeffrey B. McMahan, Nathan Tague…·John T. Ngo

The paper develops a system using viral proteases and antiviral drugs to control protein activity and gene modulation through allosteric regulation of Cre recombinase.

10 citations

protein sequenceexperimental assay

𝕏 PostBluesky

Synthetic BiologyCancer CellPeer-reviewedSep 8, 2022

Engineering clinically-approved drug gated CAR circuits

Hui-Shan Li, Nicole M. L. Wong, Elliot P. Tague…·Wilson W. Wong

The paper develops drug-gated CAR circuits using NS3 protease domains and FDA-approved inhibitors to enhance CAR T cell therapy safety and specificity.

116 citationstop 1%

humanexperimental assay

𝕏 PostBluesky